Pharma channel feed

Ex­clu­sive: Drug­mak­ers plan Trump meet­ing next week amid Wash­ing­ton health shake­ups

3 months ago
FDA+

How Bain’s $3.3B deal for cen­turies-old Tan­abe Phar­ma came to fruition

3 months ago
Deals

Up­dat­ed: Mod­er­na re­ports $238M man­u­fac­tur­ing write-down as cuts, new vac­cines shape 2025

3 months ago
Manufacturing

Labs fear fu­ture fund­ing cuts with Trump ad­min­is­tra­tion ac­tions in lim­bo

3 months ago
R&D

Up­dat­ed: Kennedy is con­firmed to lead HHS, putting an­ti-vac­cine ad­vo­cate and drug in­dus­try skep­tic atop US health pro­grams

3 months ago
People

Newleos, a new biotech with $93.5M, re­pur­pos­es Roche's ex­per­i­men­tal CNS drugs

3 months ago
Startups
Deals

NIH’s fund­ing cut plan pos­es chal­lenges for re­searchers de­spite court halt

3 months ago
FDA+

Pfiz­er wins ap­proval in new in­di­ca­tion for blood can­cer drug Ad­cetris

3 months ago
R&D
FDA+

Bio­gen gets $250M in Roy­al­ty Phar­ma deal for Phase 3 lu­pus pro­gram

3 months ago
Deals

New CMO Di­et­mar Berg­er high­lights Gilead’s ‘unique sit­u­a­tion’ and its HIV am­bi­tions

3 months ago
People
R&D

Spring­Works lands FDA ap­proval for nerve tu­mor treat­ment

3 months ago
R&D
FDA+

Tra­vere plans to seek ex­pand­ed la­bel for kid­ney drug de­spite failed tri­al

3 months ago
FDA+

Bio­haven lands pri­or­i­ty re­view on sec­ond-chance ap­pli­ca­tion for neu­rode­gen­er­a­tive drug

3 months ago
FDA+

What will phar­ma's share buy­back shop­ping spree mean for M&A?

3 months ago

No­var­tis re­turns for its an­ti­co­ag­u­lant in up to $3.1B buy of Black­stone’s An­thos

3 months ago
Deals

Ver­tex op­er­a­tions chief Stu­art Ar­buck­le to re­tire

3 months ago
People

Up­dat­ed: Judge halts NIH cuts na­tion­wide af­ter groups, 22 states sue

3 months ago
Law

Mer­ck KGaA con­firms in­ter­est in ac­quir­ing can­cer biotech Spring­Works

3 months ago
R&D

Eli Lil­ly inks $630M deal for Phase 1 MASH can­di­date

3 months ago
Deals

Trump’s tar­iff im­pact like­ly ‘min­i­mal’ for brand-name drug­mak­ers, man­u­fac­tur­ing part­ners

3 months ago
China
Manufacturing

Hims’ Su­per Bowl ad has drawn crit­i­cism from law­mak­ers — and now No­vo Nordisk

3 months ago
Health Tech

Decade af­ter $8B deal, Roche of­floads In­ter­Mune to mys­te­ri­ous spe­cial­ty phar­ma

3 months ago
Deals

Ab­b­Vie wins FDA ap­proval for new an­tibi­ot­ic to treat com­plex in­tra-ab­dom­i­nal in­fec­tions

3 months ago
FDA+

Sanofi, As­traZeneca back Teva's call to re­hear case on patent list­ings

3 months ago
Law
First page Previous page 13141516171819 Next page Last page
A service from the Financial Times